The main goal of treating optic<unk> s is to preserve vision for as long as possible. The tumor’s slow & self-limiting growth indicates that it is not immediately problematic in most benign cases, with long-term studies showing that people with optic<unk>  may still have stable functional vision without intervention. As a result, the first & preferred course of action is usually observation of optic<unk>  over time. Once the first signs of visual deterioration and/or tumor progression are observed, interventional treatments will then commence. These include radiation therapy, chemotherapy and surgical excision. While being the most effective therapy, radiation has shown damaging effects on the already compromised intellect as well as an increase in vascular issues & second tumor formation in children with neurofibromatosis 1. However, fractionated stereotactic radiation therapy (FSRT) is gaining traction as the most preferred interventional treatment for<unk>  due to its combination of the therapeutic efficiency of radiation therapy without the negative side effects. Chemotherapy has also been shown to be a safer alternative to most radiation therapies & surgery for very young children (under the age of 3). However, the optimal chemotherapeutic therapy has not been defined, with risks of different toxicities still observed in older children. Surgery is considered the final choice of treatment, due to the high risk of blindness & damage to the affected eye. It is considered in only certain scenarios, such as relieving a cosmetically unappealing bulging eye (exophthalmos), removing an enlarging and/or expanding tumor or a combination of both.
Optic nerve glioma
Optic nerve tumor
Optic nerve sheath meningioma
Intraocular schwannoma
Intraocular lymphoma
Labyrinthine fistula
Orbital lymphoma
Autoimmune optic neuropathy